In summary, we have identified a novel pain cascade, IL-1β (cancer-inoculated region) → ephrin B1 (DRGs) → NR2B (spinal cord) → pain, that may be responsible for the development of opioid-resistant pain in the mouse model of cancer-induced pain. Here, IL1B is linked to cancer.